Funding critical research
for children who
cannot wait.
Your support funds groundbreaking research and early-phase clinical trials working toward safer, more effective treatments.
Secure giving through Qgiv / Bloomerang · opens in a new tab.
- #1
- Cancer is the #1 cause of non-accidental death in children under 20
- 1 in 260
- 1 in 260 children will develop cancer before their 20th birthday
- 100+
- There are over 100 subtypes of pediatric cancers
- 11.1M
- 11.1 million children will die before the year 2050 if we stop investing in research
Cause-of-death definition: National Cancer Institute (opens in a new tab). Global projection: Lancet Oncology Commission (opens in a new tab). Read PCF’s impact record.
Childhood Cancer Awareness Month (CCAM)
Secure giving through Qgiv / Bloomerang · opens in a new tab.
Get loud!
Less than 4 percentIs not enough
Less than 4% of all federal cancer research funding is allocated to children.
Pushing the Science Forward
Explore all research
Alice Lee, MD
Children’s Hospital at Montefiore · Bronx, NY
Pediatric Early Phase Clinical Trials Program
Expanding early-phase trial access for underserved children
The Pediatric Oncology Early Phase Clinical Trial Program (PEPCTP) focuses on patients with relapsed/refractory disease who are unable to access novel oncology therapies, in an underserved and under-resourced patient population.
Why it matters: The program has grown to offer many studies and new therapies to children whose cancers are difficult to treat.
PCF support helps sustain the program’s trial infrastructure and expand access close to home.
The Urgency
Children with cancer cannot wait for the next breakthrough — they need it now.
Secure giving through Qgiv / Bloomerang · opens in a new tab.